Capital International, Inc. Gilead Sciences, Inc. Transaction History

Capital International, Inc.

$7.23 Billion
Q2 2024

A detailed history of Capital International, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital International, Inc. holds 236,106 shares of GILD stock, worth $21.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

236,106

Previous 234,917 0.51%

Holding current value

$21.3 Million

Previous $17.2 Million 5.86%

% of portfolio

0.22%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $75,085 - $86,654	1,189 Added 0.51%	236,106 $16.2 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $3.35 Million - $4.09 Million	46,848 Added 24.91%	234,917 $17.2 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $6.04 Million - $6.84 Million	82,367 Added 77.92%	188,069 $15.2 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.57 Million - $1.71 Million	21,222 Added 25.12%	105,702 $7.92 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $5.27 Million - $6.01 Million	69,339 Added 457.96%	84,480 $6.51 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $124,778 - $142,161	1,614 Added 11.93%	15,141 $1.26 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $424,835 - $609,916	6,817 Added 101.59%	13,527 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $399,513 - $456,347	6,710 New	6,710 $414,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.9 Million - $2.14 Million	-32,863 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $294,523 - $369,069	-5,085 Reduced 13.4%	32,863 $1.95 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $2.92 Million - $3.32 Million	-45,037 Reduced 54.27%	37,948 $2.76 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $336,419 - $362,959	-4,970 Reduced 5.65%	82,985 $5.8 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.54 Million - $1.68 Million	-24,223 Reduced 21.59%	87,955 $6.06 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $934,920 - $1.07 Million	-15,582 Reduced 12.2%	112,178 $7.25 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $395,643 - $450,817	6,984 Added 5.78%	127,760 $7.44 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $965,965 - $1.21 Million	-15,555 Reduced 11.41%	120,776 $7.63 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $479,107 - $556,332	6,623 Added 5.11%	136,331 $10.5 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.46 Million - $4.43 Million	55,188 Added 74.06%	129,708 $9.7 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $1.75 Million - $1.93 Million	-28,415 Reduced 27.6%	74,520 $4.84 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $6.43 Million - $7.1 Million	102,935 New	102,935 $6.52 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $18,133 - $20,314	-290 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $28,211 - $36,814	-466 Reduced 61.64%	290 $18,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $511,362 - $566,172	-7,174 Reduced 90.47%	756 $58,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $6,488 - $7,568	-100 Reduced 1.25%	7,930 $562,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $29,136 - $35,520	400 Added 5.24%	8,030 $605,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $342,943 - $402,566	-4,820 Reduced 38.71%	7,630 $547,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $897,769 - $1.06 Million	12,450	12,450 $1.01 Million

Others Institutions Holding GILD

# of Institutions

1,904

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Gilead Sciences, Inc. Transaction History